- Accueil >
- Publications >
- Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients
Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients
1 juil. 2021European Journal of Nuclear Medicine and Molecular Imaging
Auteurs
Romain-David Seban, Laurence Champion, Lawrence H. Schwartz, Laurent Dercle